Focal Interest
Focal Interest

Combination therapy

  1. RP-HPLC accurately quantified metoprolol and enalapril maleate
    RP-HPLC method for simultaneous quantification of metoprolol and enalapril maleate using environmentally sustainable approach with recovery rates of 98–102% and validation per ICH criteria.
  2. Combination therapy showed a temporary response in metastatic DDCS
    Case report demonstrates promising response to pembrolizumab and pazopanib combination therapy in metastatic dedifferentiated chondrosarcoma, highlighting emerging systemic treatment options.